Sulfaphenazole
Sulfaphenazole is an inhibitor of CYP2C9 (Ki: 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Ki: 63/29 μM for CYP2C8/CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19) . At 10 μM, sulfaphenazole has been shown to inhibit endothelium-derived hyperpolarizing factor synthase, a CYP450 isozyme in the porcine coronary artery homologous to CYP2C8/9 that generates reactive oxygen species in coronary endothelial cells and modulates vascular tone and homeostasis.
Product Specifications
CAS Number
526-08-9
Product Name Alternative
BRN-0308518 | Sulfaphenazole | Firmazolo | Inamil
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 100 mg/mL; 318.11 mM
Smiles
Nc1ccc (cc1) S (=O) (=O) Nc1ccnn1-c1ccccc1
Molecular Formula
C15H14N4O2S
Molecular Weight
314.36
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
4-amino-N- (1-phenyl-1H-pyrazol-5-yl) benzenesulfonamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
7,8-Dichloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
7,8-Dichloro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
Lentiviral human CLEC7A shRNA (UAS) - Lentiviral human CLEC7A shRNA (UAS, GFP) (25)